Proposed Scheme for Share Capital Increase for a UK Bank

Introduction

UK banks operate within a stringent regulatory environment, with a primary focus on maintaining financial stability and protecting depositors. A key component of this is the requirement to hold sufficient regulatory capital, primarily in the form of Common Equity Tier 1 (CET1) capital, as mandated by the Basel III framework and implemented in the UK via the Capital Requirements Regulation (CRR). Consequently, a bank may need to increase its share capital for several reasons: to meet or exceed these regulatory thresholds, to fund strategic growth such as acquisitions, to invest in new technology, or to bolster its balance sheet following a period of financial stress.

This report proposes a scheme for a UK-domiciled bank, listed on the London Stock Exchange, to increase its share capital. It will detail a viable process for achieving this, focusing on a rights issue as the chosen method. The report will outline the key legal and regulatory steps, provide an indicative timeline, and conclude with an analysis of the principal advantages and disadvantages associated with such an action. The proposed scheme is designed to navigate the requirements of both UK company law and the specific regulatory landscape applicable to financial institutions.

The Process for a Share Capital Increase via a Rights Issue

A rights issue is a common method for listed companies to raise fresh equity. It involves an invitation to existing shareholders to purchase new shares in proportion to their current holding, usually at a discount to the prevailing market price. This method respects the statutory pre-emption rights of shareholders under the Companies Act 2006 (CA 2006), making it a favoured approach. The process can be broken down into five distinct phases.

Phase 1: Board Approval and Preparatory Steps

The process begins internally. The bank's Board of Directors must meet to formally resolve to increase the company's share capital. Key decisions at this stage include the total amount of capital to be raised and the proposed structure of the rights issue, including the ratio of new shares to existing shares and the subscription price.

The Board must ensure it has the necessary legal authority. Under section 551 of the CA 2006, directors require authorisation from shareholders to allot new shares. While many companies have standing authority approved at their Annual General Meeting (AGM), a large capital increase may exceed this limit, necessitating fresh shareholder approval. The bank's Articles of Association must also be reviewed to ensure they do not contain any provisions that would restrict the proposed share issue.

At this point, the bank will formally appoint a team of external advisors. This typically includes:

• An Investment Bank: To act as sponsor, financial advisor, and underwriter. The underwriter provides a crucial guarantee by agreeing to purchase any shares not subscribed for by existing shareholders, ensuring the bank receives the full amount of capital sought.
• Legal Advisors: To advise on compliance with the CA 2006, the Listing Rules, the Prospectus Regulation Rules, and to conduct legal due diligence.
• Reporting Accountants: To verify the financial information included in the public-facing documentation.

Phase 2: Shareholder Approval

Unless the directors have sufficient existing authority to allot the required number of shares, a General Meeting (GM) of the shareholders must be convened. Shareholders will be sent a circular containing detailed information about the proposed rights issue and the resolutions upon which they are being asked to vote. A notice period, typically 21 clear days for a public company, must be observed before the GM can be held. The primary resolution will be an ordinary resolution (requiring a simple majority) to grant the directors authority to allot shares under s.551 CA 2006.

Phase 3: Regulatory Engagement and Documentation

This phase is particularly critical for a bank due to its regulated status. The bank must engage in an early and transparent dialogue with its primary regulator, the Prudential Regulation Authority (PRA). The PRA will need to be satisfied that the capital increase will strengthen the bank's prudential position and will review the impact on the bank's capital adequacy ratios.

Simultaneously, extensive documentation must be prepared. As the rights issue constitutes an offer of securities to the public and involves the admission of new shares to trading on a regulated market, the bank is required to publish a prospectus. This document must comply with the FCA's Prospectus Regulation Rules. The prospectus provides potential investors with comprehensive information about the bank and the offer, including a detailed description of the business, audited financial statements, and a significant section on risk factors. The draft prospectus must be submitted to the Financial Conduct Authority (FCA) for review and approval before it can be published.

Phase 4: Execution of the Rights Issue

Following shareholder and regulatory approval, the rights issue can be launched. This involves:

1. Announcement: The terms of the rights issue are announced to the market via a Regulatory Information Service (RIS).
2. Trading Begins: The existing shares start trading 'ex-rights', meaning the right to subscribe for the new shares is no longer attached to them. The rights themselves may be traded separately as 'nil-paid rights'.
3. Subscription Period: Provisional Allotment Letters are sent to qualifying shareholders, who then have a subscription period, typically lasting at least 10 working days, to decide their course of action. They can either take up their rights in full, sell their rights in the market, or do a combination of both (known as 'tail-swallowing').
4. Rump Placing: If shareholders let their rights lapse, these unsubscribed shares (the 'rump') are typically sold in the market by the underwriter, with any premium achieved over the subscription price (less expenses) being paid to the relevant shareholders.

Phase 5: Post-Completion

Once the subscription period closes, the results of the rights issue are announced. The new shares are then formally allotted and are admitted to official listing and trading on the London Stock Exchange. Finally, the bank must complete post-completion formalities, including filing a Return of Allotment of Shares (Form SH01) at Companies House within one month of the allotment.

Indicative Timeline

A rights issue is a complex undertaking, and a realistic timeline is essential for planning. A typical schedule would be as follows:

• Weeks 1-4: Internal preparation, board meetings, and appointment of advisors.
• Weeks 5-8: Drafting of the prospectus and shareholder circular. Initial engagement with the PRA and submission of the draft prospectus to the FCA.
• Week 9: Announcement of the proposed rights issue and dispatch of the GM circular to shareholders.
• Week 12: General Meeting held to obtain shareholder approval.
• Week 13: Final approval of the prospectus from the FCA. Formal announcement of the rights issue terms to the market.
• Weeks 14-16: Subscription period for shareholders. Trading of nil-paid rights.
• Week 17: Announcement of the results of the rights issue. Allotment and admission of new shares to trading.

This indicative schedule suggests the entire process would take approximately four to five months from the initial board decision to the final admission of the new shares.

Pros and Cons of a Share Capital Increase

Pros

1. Enhanced Regulatory Capital: The primary benefit for a bank is the strengthening of its capital base, specifically its CET1 ratio. This enhances its ability to absorb potential losses, increases financial resilience, and ensures compliance with the strict capital requirements set by the PRA (Prudential Regulation Authority, 2023).
2. Funding for Strategic Objectives: New equity provides permanent capital that can be used to fund expansion, make acquisitions, or invest in critical infrastructure without incurring additional debt and associated interest payments.
3. Increased Market Confidence: A successful and well-supported capital raise can signal strength and proactive management to the market, reassuring depositors, creditors, and investors about the bank's long-term stability.
4. No Repayment Obligation: Unlike debt financing, equity capital does not have a maturity date or a mandatory repayment schedule, providing greater financial flexibility.

Cons

1. Dilution of Existing Shareholders: The issuance of new shares reduces the proportionate ownership stake of existing shareholders. It can also lead to a dilution of earnings per share (EPS), which may negatively affect the share price in the short term.
2. Significant Cost and Management Time: A rights issue is an expensive exercise. Fees for underwriters, lawyers, and accountants can be substantial, often running into millions of pounds. It also consumes a significant amount of senior management's time and attention.
3. Market Execution Risk: The success of the issue is dependent on market conditions at the time of launch. A sharp fall in the bank's share price or a general market downturn could jeopardise the offering or force the bank to offer a larger discount, making the fundraising less efficient.
4. Negative Signalling: In some circumstances, a capital raise, particularly if perceived as being forced by regulators, can be interpreted by the market as a sign of distress or underlying problems within the bank, potentially damaging confidence.

Conclusion

Increasing share capital via a rights issue is a well-established but demanding process for a UK bank. It provides an effective mechanism to raise the permanent capital necessary for regulatory compliance and strategic growth. However, the procedure is governed by a complex web of company law and financial regulation, requiring meticulous planning, expert advice, and careful engagement with both shareholders and regulators. While the benefits of a strengthened balance sheet and enhanced market confidence are significant, they must be weighed against the considerable costs, the dilutive effect on existing shareholders, and the inherent market risks of the process. For a bank, a successful capital increase is therefore not merely a financial transaction but a critical exercise in corporate governance and regulatory management.

References

• Companies Act 2006.
• French, D., Mayson, S. and Ryan, C. (2022) Mayson, French & Ryan on Company Law. 39th edn. Oxford: Oxford University Press.
• Financial Conduct Authority (FCA). (2023) Prospectus Regulation Rules Sourcebook (PRR). FCA Handbook. Available at: [https://www.handbook.fca.org.uk/handbook/PRR.pdf](https://www.handbook.fca.org.uk/handbook/PRR.pdf) (Accessed: 15 October 2023).
• Prudential Regulation Authority. (2023) PRA Rulebook. Bank of England. Available at: [https://www.bankofengland.co.uk/prudential-regulation/pra-rulebook](https://www.bankofengland.co.uk/prudential-regulation/pra-rulebook) (Accessed: 15 October 2023).